We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
26
Elevance Health
ELV
$84.7B
$1.64M 0.58%
3,192
+590
+23% +$300K
WFC icon
27
Wells Fargo
WFC
$264B
$1.64M 0.58%
39,599
+24,062
+155% +$1.07M
UNH icon
28
UnitedHealth
UNH
$365B
$1.6M 0.56%
3,013
+682
+29% +$361K
FTNT icon
29
Fortinet
FTNT
$119B
$1.56M 0.55%
+28,752
New +$1.5M
DAL icon
30
Delta Air Lines
DAL
$59.5B
$1.48M 0.52%
+44,993
New +$1.49M
RF icon
31
Regions Financial
RF
$26.9B
$1.45M 0.51%
67,464
+34,076
+102% +$739K
SLB icon
32
SLB Ltd
SLB
$79.7B
$1.45M 0.51%
27,094
+6,216
+30% +$310K
AMAT icon
33
Applied Materials
AMAT
$417B
$1.43M 0.51%
+14,677
New +$1.41M
UNP icon
34
Union Pacific
UNP
$174B
$1.43M 0.51%
6,901
-825
-11% -$169K
DFS
35
DELISTED
Discover Financial Services
DFS
$1.43M 0.51%
+14,601
New +$1.47M
HBAN icon
36
Huntington Bancshares
HBAN
$35.9B
$1.42M 0.5%
100,478
+33,592
+50% +$486K
ZS icon
37
Zscaler
ZS
$28.9B
$1.41M 0.5%
12,585
+8,288
+193% +$1.13M
SYF icon
38
Synchrony
SYF
$25.5B
$1.41M 0.5%
+42,795
New +$1.47M
URI icon
39
United Rentals
URI
$71.2B
$1.4M 0.49%
3,926
+1,076
+38% +$354K
ULTA icon
40
Ulta Beauty
ULTA
$23.3B
$1.39M 0.49%
2,973
+1,213
+69% +$523K
BNY
41
Bank of New York Mellon
BNY
$109B
$1.39M 0.49%
+30,578
New +$1.31M
SPLK
42
DELISTED
Splunk Inc
SPLK
$1.39M 0.49%
16,155
+7,429
+85% +$600K
PCAR icon
43
PACCAR
PCAR
$69.8B
$1.39M 0.49%
+21,071
New +$1.38M
TSCO icon
44
Tractor Supply
TSCO
$18.4B
$1.38M 0.49%
+30,775
New +$1.31M
HPE icon
45
Hewlett Packard
HPE
$72B
$1.38M 0.49%
+86,521
New +$1.28M
GILD icon
46
Gilead Sciences
GILD
$168B
$1.38M 0.49%
+16,083
New +$1.27M
CAT icon
47
Caterpillar
CAT
$388B
$1.37M 0.49%
+5,732
New +$1.25M
LUV icon
48
Southwest Airlines
LUV
$22.3B
$1.35M 0.48%
+40,061
New +$1.44M
MCHP icon
49
Microchip Technology
MCHP
$44B
$1.35M 0.48%
19,198
+7,142
+59% +$492K
JCI icon
50
Johnson Controls International
JCI
$93.7B
$1.34M 0.48%
+21,010
New +$1.29M
1
2
3 4 5

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.